Associate Scientist at Mediar Therapeutics - Cambridge, MA, US
Chief Medical Officer
Contact Jeffrey Bornstein
senior director, antibody engineering
Contact Daniel Tavares
Senior Scientist
Contact Erin Devine
Scientist II
Contact Katherine Lamm
Scientist
Contact Saroj Nepal
Head of Pharmacology and Translational Sciences
Contact Christopher Espelin
Drugging the myofibroblast: a new approach to treating fibrosis.